Published in Cancer Weekly, December 27th, 2005
"To identify genes that could serve as targets for novel cancer therapeutics, we used a bioinformatic analysis of microarray data comparing gene expression between normal and tumor-derived primary human tissues."
"From this approach," wrote D. Gray and colleagues, Genentech Inc., "we have found that maternal embryonic leucine zipper kinase (Melk), a member of the AMP serine/threonine kinase family,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.